Q1e to mark low point amid organic decline, but we expect solid earnings development in subsequent quarters. Low valuation and in good shape for eventual market recovery.
Still high uncertainty, but Elanders is making improvements and earnings should benefit from improved demand. 10x adj. EBITA after -40% one-year total return.
We expect Elanders to report Q3 net sales of SEK 3,744m, -6% y-o-y (-13% organic, +7% FX, 0% M&A), anticipating relatively larger organic declines in the Electronics and Industrials segments.
Q1 in line with prel. figures, no surprise. Marginally lower adj. EBITA, but higher net financials. Divesting Atlanta Print business might be an option.